|
Volumn , Issue 6, 2016, Pages CD008334-
|
Biologic interventions for fatigue in rheumatoid arthritis
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABATACEPT;
ADALIMUMAB;
ANTIRHEUMATIC AGENT;
CANAKINUMAB;
CERTOLIZUMAB PEGOL;
ETANERCEPT;
GAMMA INTERFERON;
GOLIMUMAB;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
RITUXIMAB;
TOCILIZUMAB;
ANTAGONISTS AND INHIBITORS;
ARTHRITIS, RHEUMATOID;
COMPLICATION;
FATIGUE;
HUMAN;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ABATACEPT;
ADALIMUMAB;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CERTOLIZUMAB PEGOL;
ETANERCEPT;
FATIGUE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLIXIMAB;
INTERFERON-GAMMA;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RITUXIMAB;
|
EID: 84982106340
PISSN: None
EISSN: 1469493X
Source Type: Journal
DOI: 10.1002/14651858.CD008334.pub2 Document Type: Article |
Times cited : (91)
|
References (0)
|